- Report number
- COA8771
- Batch number
- SNA-26-001
- Certificate issued
- September 6, 2026
- Batch status
- Current batch
- Sample name on report
- NAD+ 500mg
- Labelled content
- 500 mg
Reported laboratory results.
| Test | Result | Method | Lab status |
|---|---|---|---|
| Identity | NAD+ | LC-MS/MS | Passed — Conforms Conforms |
| Content | 502.24 mg | HPLC Quantitation | Passed — Conforms Conforms |
| Overall Purity | 99.82% | RP-HPLC (214 nm) | Passed — Conforms Conforms |
| Endotoxin | <0.05 EU/ml | USP 85 | Passed — Conforms Conforms |
Sample received: 2026-09-01
Sample type: White lyophilized powder
Reported molecular weight: 663.2 g/mol
Laboratory verification
Check the source.
Enter COA8771 on the laboratory’s verification page to look up this certificate.
These findings are reported by Bioviridian for the identified sample. Refer to the original PDF for the chromatograms, full context and laboratory certification. Tests not shown here are not implied.
